Tapewire

Nasdaq · USD

EQ

Equillium, Inc.

Export transactions ↓
Tapewire entity
6560
SEC CIK
0001746466
Parsed reports
177

Last 12 months

Inside the activity.

0 purchase rows · 20 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202503
Jan 202601
Feb 202604
Mar 202602
Apr 202600
May 202605
Jun 202603
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 14, 2025 Filed Feb 19, 2025 19:40 UTC
Steel Bruce D.Director · President and CEO · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 245,000 Not disclosed Strike: $0.79 Not disclosed
Disclosure

SEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 9

Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 245,000

Underlying: Common Stock · 245,000 shares

Expires 2031-01-03

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 19:40 UTC
Steel Bruce D.Director · President and CEO · 10% owner
Disposition to issuerEmployee Stock Option (right to buy) · Derivative 100,110 Not disclosed Strike: $3.53 Not disclosed
Disclosure

SEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 8

Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100,110 shares

Expires 2030-05-27

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 19:40 UTC
Steel Bruce D.Director · President and CEO · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 100,110 Not disclosed Strike: $0.79 Not disclosed
Disclosure

SEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 7

Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,110

Underlying: Common Stock · 100,110 shares

Expires 2030-05-27

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 19:40 UTC
Steel Bruce D.Director · President and CEO · 10% owner
Disposition to issuerEmployee Stock Option (right to buy) · Derivative 60,000 Not disclosed Strike: $2.80 Not disclosed
Disclosure

SEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 6

Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 60,000 shares

Expires 2030-05-18

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 19:40 UTC
Steel Bruce D.Director · President and CEO · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 60,000 Not disclosed Strike: $0.79 Not disclosed
Disclosure

SEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 5

Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2030-05-18

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 19:40 UTC
Steel Bruce D.Director · President and CEO · 10% owner
Disposition to issuerEmployee Stock Option (right to buy) · Derivative 100,000 Not disclosed Strike: $4.75 Not disclosed
Disclosure

SEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 4

Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100,000 shares

Expires 2029-12-09

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 19:40 UTC
Steel Bruce D.Director · President and CEO · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 100,000 Not disclosed Strike: $0.79 Not disclosed
Disclosure

SEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 3

Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2029-12-09

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 19:40 UTC
Steel Bruce D.Director · President and CEO · 10% owner
Disposition to issuerEmployee Stock Option (right to buy) · Derivative 44,352 Not disclosed Strike: $7.16 Not disclosed
Disclosure

SEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 2

Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 44,352 shares

Expires 2029-02-12

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 19:40 UTC
Steel Bruce D.Director · President and CEO · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 44,352 Not disclosed Strike: $0.79 Not disclosed
Disclosure

SEC source: 0001415889-25-004760 · form4-02202025_120249.xml · derivative · entry 1

Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,352

Underlying: Common Stock · 44,352 shares

Expires 2029-02-12

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 00:33 UTC
Keyes Jason AChief Financial Officer
Disposition to issuerEmployee Stock Option (right to buy) · Derivative 175,000 Not disclosed Strike: $1.06 Not disclosed
Disclosure

SEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 10

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 175,000 shares

Expires 2033-01-02

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 00:33 UTC
Keyes Jason AChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 175,000 Not disclosed Strike: $0.79 Not disclosed
Disclosure

SEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 9

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2033-01-02

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 00:33 UTC
Keyes Jason AChief Financial Officer
Disposition to issuerEmployee Stock Option (right to buy) · Derivative 125,000 Not disclosed Strike: $3.86 Not disclosed
Disclosure

SEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 8

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 125,000 shares

Expires 2032-01-18

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 00:33 UTC
Keyes Jason AChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 125,000 Not disclosed Strike: $0.79 Not disclosed
Disclosure

SEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 7

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2032-01-18

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 00:33 UTC
Keyes Jason AChief Financial Officer
Disposition to issuerEmployee Stock Option (right to buy) · Derivative 100,000 Not disclosed Strike: $5.03 Not disclosed
Disclosure

SEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 6

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 100,000 shares

Expires 2031-01-03

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 00:33 UTC
Keyes Jason AChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 100,000 Not disclosed Strike: $0.79 Not disclosed
Disclosure

SEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 5

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2031-01-03

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 00:33 UTC
Keyes Jason AChief Financial Officer
Disposition to issuerEmployee Stock Option (right to buy) · Derivative 90,000 Not disclosed Strike: $2.45 Not disclosed
Disclosure

SEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 4

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 90,000 shares

Expires 2029-12-09

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 00:33 UTC
Keyes Jason AChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 90,000 Not disclosed Strike: $0.79 Not disclosed
Disclosure

SEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 3

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2029-12-09

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 00:33 UTC
Keyes Jason AChief Financial Officer
Disposition to issuerEmployee Stock Option (right to buy) · Derivative 70,000 Not disclosed Strike: $2.45 Not disclosed
Disclosure

SEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 2

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 70,000 shares

Expires 2029-02-12

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
February 14, 2025 Filed Feb 20, 2025 00:33 UTC
Keyes Jason AChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 70,000 Not disclosed Strike: $0.79 Not disclosed
Disclosure

SEC source: 0001415889-25-004756 · form4-02202025_120235.xml · derivative · entry 1

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2029-02-12

F2 · price: On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
January 23, 2025 Filed Jan 24, 2025 23:37 UTC
Keyes Jason AChief Financial Officer
SaleCommon Stock 10,000 $0.65 $6,500.00
Disclosure

SEC source: 0001415889-25-002070 · form4-01242025_110117.xml · nonDerivative · entry 1

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By The Keyes Trust Dated September 10, 2004

Disclosed balance after: 37,720

F1 · kind: The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.62 to $0.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 23:26 UTC
Tom PennyPrincipal Accounting Officer
GrantEmployee Stock Option (right to buy) · Derivative 125,000 $0.00 Strike: $0.77 $0.00
Disclosure

SEC source: 0001415889-25-000858 · form4-01062025_110145.xml · derivative · entry 1

Tom Penny · CIK 0002012180 · Principal Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2035-01-01

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 23:09 UTC
Zedelmayer ChristineSr. Vice President and COO
GrantEmployee Stock Option (right to buy) · Derivative 175,000 $0.00 Strike: $0.77 $0.00
Disclosure

SEC source: 0001415889-25-000841 · form4-01062025_110148.xml · derivative · entry 1

Zedelmayer Christine · CIK 0001797818 · Sr. Vice President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2035-01-01

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 23:06 UTC
Connelly StephenDirector · Chief Scientific Officer
GrantEmployee Stock Option (right to buy) · Derivative 175,000 $0.00 Strike: $0.77 $0.00
Disclosure

SEC source: 0001415889-25-000838 · form4-01062025_110104.xml · derivative · entry 1

Connelly Stephen · CIK 0001746808 · Director · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2035-01-01

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 23:21 UTC
BRADBURY DANIELDirector · EXECUTIVE CHAIRMAN · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $0.77 $0.00
Disclosure

SEC source: 0001415889-25-000852 · form4-01062025_110151.xml · derivative · entry 1

BRADBURY DANIEL · CIK 0001236397 · Director · EXECUTIVE CHAIRMAN · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-01-01

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 18:24 UTC
Steel Bruce D.Director · President and CEO · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 410,000 $0.00 Strike: $0.77 $0.00
Disclosure

SEC source: 0001415889-25-000856 · form4-01062025_110153.xml · derivative · entry 1

Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 410,000

Underlying: Common Stock · 410,000 shares

Expires 2035-01-01

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
January 02, 2025 Filed Jan 6, 2025 23:11 UTC
Keyes Jason AChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 175,000 $0.00 Strike: $0.77 $0.00
Disclosure

SEC source: 0001415889-25-000843 · form4-01062025_110147.xml · derivative · entry 3

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2035-01-01

F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
December 11, 2024 Filed Dec 12, 2024 22:45 UTC GrantDirector Stock Option (right to buy) · Derivative 40,000 $0.00 Strike: $0.70 $0.00
Disclosure

SEC source: 0001415889-24-029164 · form4-12122024_101224.xml · derivative · entry 1

Colabuono Peter · CIK 0001819620 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2034-12-10

F1 · derivative.exercise_date: The option vests in 36 equal monthly installments following the grant date of December 11, 2024.

Read SEC document
December 10, 2024 Filed Jan 6, 2025 23:11 UTC
Keyes Jason AChief Financial Officer
GrantCommon Stock 15,000 $0.54 $8,100.00
Disclosure

SEC source: 0001415889-25-000843 · form4-01062025_110147.xml · nonDerivative · entry 1

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,913

F1 · kind: These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
November 14, 2024 Filed Nov 15, 2024 23:23 UTC
Keyes Jason AChief Financial Officer
SaleCommon Stock 10,000 $0.70 $7,000.00
Disclosure

SEC source: 0001415889-24-026987 · form4-11152024_111115.xml · nonDerivative · entry 1

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By The Keyes Trust Dated September 10, 2004

Disclosed balance after: 47,720

F1 · kind: The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.67 to $0.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 28, 2024 Filed Oct 29, 2024 20:15 UTC
Tom PennyPrincipal Accounting Officer
SaleCommon Stock 2,835 $1.25 $3,543.75
Disclosure

SEC source: 0001415889-24-025695 · form4-10292024_041001.xml · nonDerivative · entry 2

Tom Penny · CIK 0002012180 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,533

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2024.

Read SEC document
October 28, 2024 Filed Oct 31, 2024 00:59 UTC
Zedelmayer ChristineSr. Vice President and COO
SaleCommon Stock 15,000 $1.25 $18,750.00
Disclosure

SEC source: 0001415889-24-025804 · form4-10312024_121034.xml · nonDerivative · entry 1

Zedelmayer Christine · CIK 0001797818 · Sr. Vice President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 135,246

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 19, 2024.

F2 · balance_after: Includes 15,000 shares acquired by the reporting person on June 10, 2024 under the Issuer's 2018 Employee Stock Purchase Plan.

Read SEC document
October 25, 2024 Filed Oct 29, 2024 20:15 UTC
Tom PennyPrincipal Accounting Officer
SaleCommon Stock 683 $1.25 $853.75
Disclosure

SEC source: 0001415889-24-025695 · form4-10292024_041001.xml · nonDerivative · entry 1

Tom Penny · CIK 0002012180 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,368

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2024.

Read SEC document
September 26, 2024 Filed Sep 27, 2024 23:38 UTC
Keyes Jason AChief Financial Officer
SaleCommon Stock 10,000 $0.81 $8,100.00
Disclosure

SEC source: 0001415889-24-024079 · form4-09272024_110919.xml · nonDerivative · entry 1

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By The Keyes Trust Dated September 10, 2004

Disclosed balance after: 57,720

F1 · kind: The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.79 to $0.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 16, 2024 Filed Sep 17, 2024 22:14 UTC
Tom PennyPrincipal Accounting Officer
SaleCommon Stock 38,806 $0.85 $32,985.10
Disclosure

SEC source: 0001415889-24-023546 · form4-09172024_100911.xml · nonDerivative · entry 1

Tom Penny · CIK 0002012180 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,051

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 14, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.83 to $0.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3 · balance_after: Includes 15,000 shares acquired by the reporting person under the Issuer's 2018 Employee Stock Purchase Plan on June 10, 2024.

Read SEC document
July 16, 2024 Filed Jul 18, 2024 21:52 UTC
Keyes Jason AChief Financial Officer
SaleCommon Stock 10,000 $0.87 $8,700.00
Disclosure

SEC source: 0001415889-24-019776 · form4-07182024_090731.xml · nonDerivative · entry 1

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By The Keyes Trust Dated September 10, 2004

Disclosed balance after: 67,720

F1 · kind: The transactions reported on this form were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 27, 2024.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.82 to $0.9342, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
May 22, 2024 Filed May 23, 2024 18:00 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $1.43 $0.00
Disclosure

SEC source: 0001415889-24-014369 · form4-05232024_100515.xml · derivative · entry 1

MANIAN BALA S · CIK 0000941871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2034-05-22

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2024, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date.

Read SEC document
May 22, 2024 Filed May 23, 2024 21:54 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $1.43 $0.00
Disclosure

SEC source: 0001415889-24-014358 · form4-05232024_090501.xml · derivative · entry 1

Troupin Barbara · CIK 0001627886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2034-05-22

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2024, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date.

Read SEC document
May 22, 2024 Filed May 23, 2024 22:04 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $1.43 $0.00
Disclosure

SEC source: 0001415889-24-014372 · form4-05232024_100518.xml · derivative · entry 1

DEMSKI MARTHA J · CIK 0001198230 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2034-05-22

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2024, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date.

Read SEC document
May 22, 2024 Filed May 23, 2024 22:02 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $1.43 $0.00
Disclosure

SEC source: 0001415889-24-014370 · form4-05232024_100533.xml · derivative · entry 1

Pruzanski Mark · CIK 0001559569 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2034-05-22

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2024, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date.

Read SEC document
May 22, 2024 Filed May 23, 2024 21:59 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $1.43 $0.00
Disclosure

SEC source: 0001415889-24-014367 · form4-05232024_090548.xml · derivative · entry 1

McDermott Charles Douglas · CIK 0001710696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2034-05-22

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2024, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date.

Read SEC document
May 22, 2024 Filed May 23, 2024 21:56 UTC GrantStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $1.43 $0.00
Disclosure

SEC source: 0001415889-24-014364 · form4-05232024_090523.xml · derivative · entry 1

Xu Yu (Katherine) · CIK 0001843348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2034-05-22

F1 · derivative.exercise_date: The option vests in twelve equal monthly installments commencing on the grant date of May 22, 2024, provided that the option will, in any case, be fully vested on the date of the Issuer's annual meeting of stockholders following the grant date.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 23:12 UTC
Zedelmayer ChristineSr. Vice President and COO
GrantEmployee Stock Option (right to buy) · Derivative 175,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-24-000516 · doc4.xml · derivative · entry 3

Zedelmayer Christine · CIK 0001797818 · Sr. Vice President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2034-01-01

F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 23:17 UTC
Connelly StephenDirector · Chief Scientific Officer
GrantEmployee Stock Option (right to buy) · Derivative 175,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-24-000523 · doc4.xml · derivative · entry 1

Connelly Stephen · CIK 0001746808 · Director · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2034-01-01

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 23:20 UTC
BRADBURY DANIELDirector · Executive Chairman · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-24-000532 · doc4.xml · derivative · entry 1

BRADBURY DANIEL · CIK 0001236397 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2034-01-01

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 18:19 UTC
Steel Bruce D.Director · President and CEO · 10% owner
GrantEmployee Stock Option (right to buy) · Derivative 410,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-24-000529 · doc4.xml · derivative · entry 1

Steel Bruce D. · CIK 0001614997 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 410,000

Underlying: Common Stock · 410,000 shares

Expires 2034-01-01

F1 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 23:10 UTC
Keyes Jason AChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 175,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-24-000515 · doc4.xml · derivative · entry 4

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2034-01-01

F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 23:14 UTC
Rothman JoelChief Development Officer
GrantEmployee Stock Option (right to buy) · Derivative 175,000 $0.00 Strike: $0.73 $0.00
Disclosure

SEC source: 0001209191-24-000518 · doc4.xml · derivative · entry 3

Rothman Joel · CIK 0001842921 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,000

Underlying: Common Stock · 175,000 shares

Expires 2034-01-01

F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Read SEC document
December 08, 2023 Filed Jan 3, 2024 23:12 UTC
Zedelmayer ChristineSr. Vice President and COO
GrantCommon Stock 8,804 $0.58 $5,106.32
Disclosure

SEC source: 0001209191-24-000516 · doc4.xml · nonDerivative · entry 2

Zedelmayer Christine · CIK 0001797818 · Sr. Vice President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,246

F1 · kind: These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
December 08, 2023 Filed Jan 3, 2024 23:10 UTC
Keyes Jason AChief Financial Officer
GrantCommon Stock 8,805 $0.58 $5,106.90
Disclosure

SEC source: 0001209191-24-000515 · doc4.xml · nonDerivative · entry 2

Keyes Jason A · CIK 0001678152 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,913

F1 · kind: These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document
December 08, 2023 Filed Jan 3, 2024 23:14 UTC
Rothman JoelChief Development Officer
GrantCommon Stock 8,804 $0.58 $5,106.32
Disclosure

SEC source: 0001209191-24-000518 · doc4.xml · nonDerivative · entry 2

Rothman Joel · CIK 0001842921 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,150

F1 · kind: These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.